Rahul Bhargava, Director and Head of Hematology, Hematooncology, and Stem Cell Transplant at Fortis Health Care, shared a post on LinkedIn:
“High-risk myeloma remains one of the biggest unmet needs in hematology.
There is no one better than Shaji Kumar from Mayo Clinic to bring clarity to this complex space, along with Mehak Trehan.
Eagerly awaiting the 30th evening, where a high-impact discussion will help decode the challenges and evolving strategies in managing these difficult-to-treat myelomas.
The goal is simple yet powerful:
Every myeloma patient deserves the opportunity to live a decade and beyond.”
Other articles featuring Rahul Bhargava on OncoDaily.
